Trevi Therapeutics Inc.

NASDAQ: TRVI · Real-Time Price · USD
7.51
0.02 (0.27%)
At close: Aug 15, 2025, 3:59 PM
7.52
0.07%
After-hours: Aug 15, 2025, 04:10 PM EDT

Trevi Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-47.91M -29.07M -29.15M -33.94M
Depreciation & Amortization
147K 123K 43K 50K
Stock-Based Compensation
3.59M 2.25M 2.33M 2.54M
Other Working Capital
5.22M -2.8M -1.24M 678K
Other Non-Cash Items
-907K -1.17M -162K 974K
Deferred Income Tax
n/a n/a n/a -82K
Change in Working Capital
6.83M -3.85M -1.23M 1.51M
Operating Cash Flow
-38.26M -31.71M -28.18M -28.95M
Capital Expenditures
-35K -137K -159K n/a
Cash Acquisitions
n/a n/a -829K n/a
Purchase of Investments
-98.46M -9.93M -126.22M n/a
Sales Maturities Of Investments
75.6M 69.5M 19M n/a
Other Investing Acitivies
1.37M n/a 829K n/a
Investing Cash Flow
-21.53M 59.43M -107.37M n/a
Debt Repayment
-126K -9.41M -5.83M -68K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
464K -211K 11.73M -340K
Financial Cash Flow
61.48M -7.91M 111.31M 20.77M
Net Cash Flow
1.7M 19.81M -24.24M -8.17M
Free Cash Flow
-38.29M -31.85M -28.33M -28.95M